Product image of Besponsa (Inotuzumab Ozogamicin) supplied by GNH India

Besponsa

Active Ingredient:
Inotuzumab Ozogamicin
Origin:
EU

Besponsa (Inotuzumab Ozogamicin)

Besponsa (Inotuzumab Ozogamicin) is an intravenous medication used in cancer treatment. This targeted therapy is designed to help manage certain types of blood cancers by delivering a cytotoxic agent directly to cancer cells.

Manufacturer / TM Owner

Pfizer Europe Ma Eeig

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Besponsa is primarily used in the treatment of acute lymphoblastic leukemia (ALL), a type of blood cancer. It works by targeting CD22, a protein found on the surface of cancer cells, and delivering a cytotoxic agent to destroy these cells. This medication is often considered when other treatments have not been effective or are no longer suitable.

Side Effects

  • Common effects of Besponsa may include infusion-related reactions such as fever, chills, and nausea. Some patients may also experience fatigue, vomiting, and an increased risk of infection. These effects can vary from person to person and may require medical attention if they become severe.

Precautions & Warnings

  • Besponsa should be administered under the supervision of a healthcare professional. It is important to discuss any existing medical conditions, allergies, or other medications being taken before starting treatment. Regular monitoring may be necessary to manage potential side effects and ensure the safety of the patient.

Avoid Interactions

  • Besponsa may interact with other medications, particularly those that affect the immune system or blood cell production. It is important to inform your healthcare provider about all medications, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol and certain foods may also affect the efficacy and safety of Besponsa.

Frequently Asked Questions

Besponsa is used in the treatment of acute lymphoblastic leukemia (ALL), a type of blood cancer.

Besponsa is administered intravenously, typically under the supervision of a healthcare professional.

Common side effects may include fever, chills, nausea, fatigue, vomiting, and an increased risk of infection.

Besponsa may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

Precautions include regular monitoring, discussing existing medical conditions, and informing healthcare providers about all medications being taken.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Inotuzumab Ozogamicin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT